Paloma Partners Management Co lifted its stake in shares of Express Scripts Holding (NASDAQ:ESRX) by 37.5% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 54,493 shares of the company’s stock after acquiring an additional 14,856 shares during the quarter. Paloma Partners Management Co’s holdings in Express Scripts were worth $4,068,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Van ECK Associates Corp boosted its stake in Express Scripts by 5.1% during the 3rd quarter. Van ECK Associates Corp now owns 506,511 shares of the company’s stock valued at $32,072,000 after purchasing an additional 24,728 shares during the period. Victory Capital Management Inc. lifted its position in shares of Express Scripts by 12.5% in the 3rd quarter. Victory Capital Management Inc. now owns 35,421 shares of the company’s stock worth $2,243,000 after acquiring an additional 3,940 shares during the period. LMR Partners LLP bought a new stake in shares of Express Scripts in the 3rd quarter worth approximately $3,230,000. Polianta Ltd lifted its position in shares of Express Scripts by 38.9% in the 4th quarter. Polianta Ltd now owns 20,700 shares of the company’s stock worth $1,545,000 after acquiring an additional 5,800 shares during the period. Finally, Zeke Capital Advisors LLC lifted its position in shares of Express Scripts by 85.4% in the 3rd quarter. Zeke Capital Advisors LLC now owns 12,347 shares of the company’s stock worth $782,000 after acquiring an additional 5,688 shares during the period. Institutional investors own 89.08% of the company’s stock.
In related news, VP Glen D. Stettin sold 3,449 shares of the firm’s stock in a transaction on Thursday, January 11th. The stock was sold at an average price of $81.00, for a total transaction of $279,369.00. Following the completion of the sale, the vice president now directly owns 33,715 shares of the company’s stock, valued at approximately $2,730,915. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP Glen D. Stettin sold 3,448 shares of the firm’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $76.00, for a total value of $262,048.00. The disclosure for this sale can be found here. Insiders have sold a total of 21,896 shares of company stock valued at $1,617,903 over the last ninety days. Insiders own 0.68% of the company’s stock.
Express Scripts Holding (ESRX) opened at $77.00 on Wednesday. Express Scripts Holding has a twelve month low of $55.80 and a twelve month high of $85.07. The company has a quick ratio of 0.55, a current ratio of 0.67 and a debt-to-equity ratio of 0.83. The stock has a market capitalization of $43,916.79, a P/E ratio of 9.83, a PEG ratio of 0.96 and a beta of 0.94.
Express Scripts (NASDAQ:ESRX) last issued its earnings results on Tuesday, February 27th. The company reported $2.16 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.09 by $0.07. Express Scripts had a return on equity of 25.19% and a net margin of 4.51%. The business had revenue of $25.38 billion during the quarter, compared to analysts’ expectations of $25.07 billion. During the same period in the prior year, the firm posted $1.88 EPS. Express Scripts’s quarterly revenue was up 2.1% compared to the same quarter last year. research analysts predict that Express Scripts Holding will post 9.35 earnings per share for the current year.
Express Scripts announced that its board has authorized a share buyback plan on Monday, December 18th that allows the company to buyback 45,000,000 shares. This buyback authorization allows the company to repurchase shares of its stock through open market purchases. Shares buyback plans are often a sign that the company’s board of directors believes its stock is undervalued.
TRADEMARK VIOLATION NOTICE: “Express Scripts Holding (ESRX) Stake Increased by Paloma Partners Management Co” was first reported by American Banking News and is the property of of American Banking News. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at https://www.americanbankingnews.com/2018/03/14/express-scripts-holding-esrx-stake-increased-by-paloma-partners-management-co.html.
Express Scripts Company Profile
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).
Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.